Friedrik P. Wikman
About
In The Last Decade
Friedrik P. Wikman
26 papers receiving 718 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 403
- Oncology 268
- Pathology and Forensic Medicine 251
- Cancer Research 184
- Genetics 179
Countries citing papers authored by Friedrik P. Wikman
This map shows the geographic impact of Friedrik P. Wikman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrik P. Wikman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrik P. Wikman more than expected).
Fields of papers citing papers by Friedrik P. Wikman
This network shows the impact of papers produced by Friedrik P. Wikman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrik P. Wikman. The network helps show where Friedrik P. Wikman may publish in the future.
Co-authorship network of co-authors of Friedrik P. Wikman
This figure shows the co-authorship network connecting the top 25 collaborators of Friedrik P. Wikman. A scholar is included among the top collaborators of Friedrik P. Wikman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrik P. Wikman. Friedrik P. Wikman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 3 | |
| 3 | 18 | |
| 4 | 27 | |
| 5 | 6 | |
| 6 | 33 | |
| 7 | 36 | |
| 8 | 15 | |
| 9 | 21 | |
| 10 | 15 | |
| 11 | 68 | |
| 12 | 6 | |
| 13 | 18 | |
| 14 | 45 | |
| 15 | 8 | |
| 16 | Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. | 116 |
| 17 | 8 | |
| 18 | 8 | |
| 19 | 20 | |
| 20 | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.